RYVYL INC (RVYL)
(Delayed Data from NSDQ)
$1.23 USD
-0.17 (-12.14%)
Updated Apr 18, 2024 04:00 PM ET
After-Market: $1.21 -0.02 (-1.63%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth A Momentum A VGM
Price, Consensus and EPS Surprise
RVYL 1.23 -0.17(-12.14%)
Will RVYL be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for RVYL based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for RVYL
Nuvei Corporation (NVEI) Lags Q4 Earnings Estimates
Stantec (STN) Q3 Earnings Meet Estimates
RVYL: What are Zacks experts saying now?
Zacks Private Portfolio Services
Usio Inc (USIO) Reports Q3 Loss, Tops Revenue Estimates
Other News for RVYL
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
JAGX, BSGM and SXTC among mid-day movers
RYVYL Inc. Announces Cancellation of Proposed Underwritten Public Offering
Fly Intel: Pre-market Movers
Why Is Calidi Biotherapeutics (CLDI) Stock Down 51% Today?